Physician profile
Jeana Keith
NPI 1780448928
$815.64
in general payments reported to CMS, 2019-2025
16 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $438 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $181.60 | 2024 | Veozah |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $151.15 | 2024-2025 | Lifevest |
| Abbvie INC. | $77.49 | 2024-2025 | |
| Novo Nordisk INC | $62.44 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $53.50 | 2024-2025 | Airsupra, Farxiga |
| Novartis Pharmaceuticals Corporation | $44.93 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.03 | 2025 | |
| Lilly USA, LLC | $32.87 | 2024 | Mounjaro |
| Pfizer INC. | $32.17 | 2025 | |
| Kestra Medical Technology Services, INC. | $29.69 | 2025 | Assure Wcd |
| Mylan Specialty L.P. | $25.67 | 2024 | Yupelri |
| Almatica Pharma LLC | $24.31 | 2024 | Loreev Xr |
| E.R. Squibb & Sons, L.L.C. | $17.66 | 2025 | Eliquis |
| Merck Sharp & Dohme LLC | $17.53 | 2025 | Verquvo |
| Vanda Pharmaceuticals INC. | $16.18 | 2024 | Fanapt |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $13.42 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeana Keith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.